Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Hold
80,000
– – 0.02% 301
2026
Q1
$234K Hold
80,000
– – 0.02% 300
2025
Q4
$198K Hold
80,000
– – 0.02% 297
2025
Q3
$178K Hold
80,000
– – 0.02% 312
2025
Q2
$193K Hold
80,000
– – 0.03% 300
2025
Q1
$186K Hold
80,000
– – 0.03% 288
2024
Q4
$148K Hold
80,000
– – 0.02% 318
2024
Q3
$195K Hold
80,000
– – 0.03% 266
2024
Q2
$164K Hold
80,000
– – 0.03% 269
2024
Q1
$198K Hold
80,000
– – 0.04% 249
2023
Q4
$224K Hold
80,000
– – 0.04% 220
2023
Q3
$206K Hold
80,000
– – 0.05% 217
2023
Q2
$254K Hold
80,000
– – 0.05% 191
2023
Q1
$226K Hold
80,000
– – 0.05% 204
2022
Q4
$218K Buy
+80,000
New +$233K 0.05% 200

Other funds holding ABEV

CVA Family Office's ABEV Position: Q2 2026 in Review

CVA Family Office held its Ambev (ABEV) position steady in Q2 2026 at 80,000 shares worth $251K. The position accounts for 0.02% of the portfolio, ranked #301.

CVA Family Office first reported a position in ABEV in Q4 2022 and has held it in 15 quarters since. The position peaked at $254K in Q2 2023. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • CVA Family Office held 80,000 shares of Ambev worth $251K as of Q2 2026.
  • CVA Family Office left its Ambev share count unchanged in Q2 2026.
  • Ambev made up 0.02% of CVA Family Office's portfolio in Q2 2026, its #301 holding.
  • CVA Family Office first reported a position in Ambev in Q4 2022 and has held it in 15 quarters since.
  • CVA Family Office's Ambev position peaked at $254K in Q2 2023.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.